Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Drug Retail Industry Analysis

UpdatedAug 31, 2025
DataAggregated Company Financials
Companies4
  • 7D-5.3%
  • 3M20.3%
  • 1Y-33.1%
  • YTDn/a

In the last week, the Drug Retail industry is up 1.2%, with all of the companies up. In contrast, the industry has lost 33% in the last 12 months. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the Brazilian Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 31 Aug 2025R$34.1bR$62.2bR$1.4b18.8x24x0.5x
Tue, 29 Jul 2025R$27.4bR$60.2bR$1.3b17.1x20.5x0.5x
Thu, 26 Jun 2025R$30.3bR$60.2bR$1.3b18.5x22.7x0.5x
Sat, 24 May 2025R$28.8bR$60.2bR$1.3b17.4x21.5x0.5x
Mon, 21 Apr 2025R$39.0bR$58.6bR$1.3b21.1x29.3x0.7x
Wed, 19 Mar 2025R$37.0bR$58.5bR$1.3b20.4x27.9x0.6x
Fri, 14 Feb 2025R$37.0bR$56.7bR$1.4b11.6x26.3x0.7x
Sun, 12 Jan 2025R$39.4bR$56.7bR$1.4b12.1x28x0.7x
Tue, 10 Dec 2024R$44.9bR$56.7bR$1.4b12.2x31.9x0.8x
Thu, 07 Nov 2024R$48.3bR$56.6bR$1.4b14.4x34.8x0.9x
Sat, 05 Oct 2024R$47.0bR$54.8bR$1.3b16.8x37.5x0.9x
Mon, 02 Sep 2024R$50.9bR$54.8bR$1.3b17.5x40.6x0.9x
Wed, 31 Jul 2024R$50.6bR$53.1bR$1.2b30.7x41.8x1x
Fri, 28 Jun 2024R$48.5bR$53.1bR$1.2b29.4x40.1x0.9x
Sun, 26 May 2024R$48.1bR$53.1bR$1.2b19.5x38.5x0.9x
Tue, 23 Apr 2024R$47.2bR$51.4bR$1.2b30.4x40.4x0.9x
Thu, 21 Mar 2024R$51.2bR$51.4bR$1.2b32.9x43.8x1x
Sat, 17 Feb 2024R$47.0bR$49.8bR$1.1b19.3x44.4x0.9x
Mon, 15 Jan 2024R$52.5bR$49.8bR$1.1b21.9x49.6x1.1x
Wed, 13 Dec 2023R$52.4bR$49.8bR$1.1b21.2x49.5x1.1x
Fri, 10 Nov 2023R$48.2bR$49.7bR$1.0b20.1x47.5x1x
Sun, 08 Oct 2023R$51.3bR$48.1bR$948.8m20.9x54.1x1.1x
Tue, 05 Sep 2023R$51.3bR$48.1bR$948.8m22.5x54.1x1.1x
Thu, 03 Aug 2023R$53.6bR$46.0bR$1.1b23.3x50.5x1.2x
Sat, 01 Jul 2023R$54.7bR$46.0bR$1.1b22.6x51.5x1.2x
Mon, 29 May 2023R$52.7bR$46.0bR$1.1b20.7x49.6x1.1x
Wed, 26 Apr 2023R$45.7bR$43.7bR$1.1b17.2x41.8x1x
Fri, 24 Mar 2023R$41.6bR$43.5bR$1.1b15.6x38.1x1x
Sun, 19 Feb 2023R$42.6bR$41.4bR$1.0b31.5x42.1x1x
Tue, 17 Jan 2023R$43.3bR$41.4bR$1.0b31.4x42.8x1x
Thu, 15 Dec 2022R$39.9bR$41.4bR$1.0b29.2x39.5x1x
Sat, 12 Nov 2022R$42.4bR$41.1bR$1.0b31.8x42.2x1x
Mon, 10 Oct 2022R$43.4bR$39.2bR$1.0b21.6x41.3x1.1x
Wed, 07 Sep 2022R$41.4bR$39.2bR$1.0b19.6x39.5x1.1x
Price to Earnings Ratio

39.5x


Total Market Cap: R$41.4bTotal Earnings: R$1.0bTotal Revenue: R$39.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Drug Retail Industry Price to Earnings3Y Average 39.2x202320242025
Current Industry PE
  • Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.7x which is lower than its 3-year average PE of 39.2x.
  • The industry is trading close to its 3-year average PS ratio of 0.91x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 11% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Brazilian Drug Retail compare with similar industries?

BR Market2.33%
Consumer Staples1.63%
Food and Staples Retail-0.54%
Drug Retail-5.31%
Food Retail11.15%
Big Box Super Stores4.71%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PNVL3 Dimed Distribuidora de MedicamentosR$10.252.6%
+R$38.7m		1.8%PE13x
DMVF3 d1000 Varejo Farma ParticipaçõesR$4.898.2%
+R$18.7m		-31.3%PE12.7x

Latest News

RADL3
R$17.55
Raia Drogasil
7D
-6.0%
1Y
-36.3%

Brazil Aging Trends And Digital Channels Will Elevate Retail Performance

Raia Drogasil's consensus price target has increased to R$21.21, with both its future P/E and discount rate remaining largely stable, indicating steady valuation assumptions amid the upward fair value revision. What's in the News Board approved payment of BRL 131.8 million in interest on equity, equivalent to BRL 0.076940867 per share, to be paid by December 5, 2025.
PNVL3
R$10.25
Dimed Distribuidora de Medicamentos
7D
2.6%
1Y
1.8%
PGMN3
R$3.62
Empreendimentos Pague Menos
7D
-2.2%
1Y
17.5%
DMVF3
R$4.89
d1000 Varejo Farma Participações
7D
8.2%
1Y
-31.3%